Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.

Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.

Item
http://www.wikidata.org/entity/Q38914959
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities.Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.The safety of anti PD-1 therapeutics for the treatment of melanoma.Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature.Pembrolizumab use for the treatment of advanced melanoma.Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade.Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab.Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system
P2860

Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.

Item
http://www.wikidata.org/entity/Q38914959
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Eosinophilic Fasciitis and Acu ...... ient with Metastatic Melanoma.
@en
type
label
Eosinophilic Fasciitis and Acu ...... ient with Metastatic Melanoma.
@en
prefLabel
Eosinophilic Fasciitis and Acu ...... ient with Metastatic Melanoma.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Eosinophilic Fasciitis and Acu ...... ient with Metastatic Melanoma.
@en
P2093
P304
P31
P356
10.1158/2326-6066.CIR-15-0186
P433
P478
P50
P577
P698